Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.
CDC Updates HCV Screening Guidelines to Increase Linkage to Care
The CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.
Hepatitis C: What If You Do Not Treat?
Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.
New Findings Underscore Need for Universal DAA Therapy for all Persons with Hepatitis C Virus Infection
Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.
Less Than One-third of Adults with HCV Get Timely Treatment, According to New CDC Report
Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.
HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.
ACP: Ensure Adult Routine Vaccinations are Up to Date as Flu and COVID Meet Again
The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.